There's a chance for six substances to be published

These traditional Chinese medicine varieties, new opportunities come Recently, the national health and Health Commission and the State Administration of market supervision jointly issued the announcement on six new Chinese herbal medicines, such as angelica, which are traditionally food advantages (No 8, 2019) The announcement content shows that according to the provisions of the food safety law, after the safety assessment and extensive consultation, six substances such as angelica, Kaempferia, saffron, Caocao, turmeric, Piper longum are included in the material catalogue management according to the traditional Chinese medicine as well as food, which is only used as spices and condiments According to the traditional production and operation of both food and traditional Chinese medicine materials as food, their labels, instructions, advertisements, publicity information, etc shall not contain false publicity content, and shall not involve disease prevention and treatment functions Note: the substances listed in the material catalogue of traditional Chinese medicine as well as food shall conform to the provisions of the food safety law as food production and operation The above documents mean that "Angelica" and "saffron" have officially entered the regular army of "homology of medicine and food" In addition, the National Health Commission and the State Administration of Market Supervision recently jointly issued the notice on the pilot work of material management of 9 kinds of substances, including dangshen, which is traditionally both food and traditional Chinese medicine According to the notice, according to the provisions of the food safety law, through safety assessment and wide public consultation, the pilot work of production and operation of 9 substances (hereinafter referred to as food and drug substances) including dangshen, Cistanche deserticola, Dendrobium candidum, American ginseng, astragalus, Ganoderma lucidum, Cornus officinalis, Gastrodia elata and eucommia leaves will be carried out in accordance with the traditional production and operation of substances that are both food and Chinese medicinal materials Each provincial health and Health Committee, together with the market supervision bureau (Department and committee), shall, according to the actual situation of the jurisdiction, propose specific pilot programs, which shall include the types of food and drug substances to be piloted, risk monitoring plans and supporting regulatory measures, etc., which shall be submitted to the provincial people's government for approval and then to the National Health Committee and the state Market Supervision Bureau for approval The core content of the notice is to inform nine substances including dangshen, Cistanche deserticola, Dendrobium candidum, American ginseng, astragalus, Ganoderma lucidum, Gastrodia elata, Cornus officinalis and eucommia leaves to be included in the catalogue management of food and drug substances, and to enter the "production and operation pilot work" Through the study of relevant policy documents, the author has made the path and approximate time for nine substances such as Dangshen and Huangqi to enter the directory of "medicine and food homology", for your reference It has been a long time since 9 kinds of substances such as Dangshen and Huangqi were included in the list of drug and food homology Since January 11, 2018, the food department issued the draft for comments, after two years, it has finally ushered in a new situation of "production and operation pilot" According to the spirit of the draft, dynamic management is expected to be implemented by the end of 2021 At that time, the provincial health and family planning administrative department and the national food and drug substance agency can put forward suggestions for catalog adjustment, and it is expected to adjust 9 substances such as Dangshen and Huangqi to be included in the drug and food homology catalog after demonstration : for the 15 varieties involved in the 2014 edition, due to the draft for comments, the relevant departments have not formally replied, that is, they have not yet promulgated and implemented Among the 15 varieties, 12 varieties, such as ginseng (planted artificially), Rose (red rose with double petals), pine pollen, cloth dregs leaf, Prunella vulgaris, angelica, Kaempferia, saffron, grass fruit, turmeric, Piper longum, have been issued and implemented in batches in the relevant documents; the remaining varieties (honeysuckle, coriander, Pueraria) have not been officially issued and implemented The adjustment of "medicine and food homology" catalogue has far-reaching influence on traditional Chinese medicine enterprises; in a word, it will have the following three advantages for traditional Chinese medicine enterprises at least: (1) The demand for raw materials with the same origin of medicine and food is increasing rapidly, which is beneficial to the planting and processing industry in the production area Chinese herbal medicine / Chinese herbal pieces belong to the category of drugs, which can only be circulated and sold in the pharmaceutical channels, and the dosage is greatly limited Even with the agricultural and sideline products, the sales volume is extremely limited Once it enters the drug food homology catalogue, all kinds of food and health food will bloom, and its raw material demand will increase significantly, which will benefit the planting and processing industry of related products (2) Usher in the upsurge of new product development With the increase of "homology of medicine and food" catalogue, the upsurge of new product development will surely come At present, Chinese medicine and food homologous varieties mostly enter the market in the form of Chinese herbal pieces or medicinal meals, which can meet the daily needs of residents However, the preparation is simple, the technology content of products is low, the investment of enterprises in the development of new products is insufficient, and the added value is low, which leads to a long history of application of medicine and food homologous varieties, but it is difficult to achieve a big breakthrough Therefore, in the development of new products, it is necessary to keep pace with the times, learn from Japan, South Korea, European and American countries, improve the scientific and technological content, and enrich the product forms (such as extract, granule, concentrate, wall breaking powder, freeze-drying agent, etc.), so as to have stronger competitiveness in market development At the same time, it is a shortcut to cooperate with universities / scientific research institutes to directly transform the previous research results, so as to facilitate the early start of new products and occupy the blank market as soon as possible (3) Promote the transformation and upgrading of traditional Chinese medicine / herbal pieces Enterprises In recent two years, the supervision of Chinese herbal pieces has been increasing, especially since the implementation of the new drug management law on December 1, 2019, the punishment of drug violations has been intensified, reflecting the spirit of "four strictest", which has caused unprecedented pressure on Chinese Herbal Pieces enterprises Therefore, the transformation and upgrading of traditional Chinese medicine / herbal pieces enterprises has become inevitable to adapt to market changes.